Mesothelin-specific CAR T cells bind mesothelin on target cells and kill via perforin/granzyme release and death-receptor (Fas/FasL) pathways, with cytokine-mediated effects; a PD-1 dominant-negative receptor blocks PD-1/PD-L1 inhibition.